BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29927924)

  • 1. Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - A prospective cohort study.
    Van Poucke S; Huskens D; Van der Speeten K; Roest M; Lauwereins B; Zheng MH; Dehaene S; Penders J; Marcus A; Lancé M
    PLoS One; 2018; 13(6):e0193657. PubMed ID: 29927924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis.
    Falcón Araña L; Fuentes-García D; Roca Calvo MJ; Hernández-Palazón J; Gil Martínez J; Cascales Campos PA; Acosta Villegas FJ; Parrilla Paricio P
    Cir Esp; 2015 Oct; 93(8):496-501. PubMed ID: 25882334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort analysis.
    Hurdle H; Bishop G; Walker A; Moazeni A; Paloucci EO; Temple W; Mack L; Shing M
    Can J Anaesth; 2017 Nov; 64(11):1144-1152. PubMed ID: 28853010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)-A Systematic Review.
    Lundbech M; Damsbo M; Krag AE; Hvas AM
    Semin Thromb Hemost; 2024 Apr; 50(3):474-488. PubMed ID: 36828005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study.
    Lentschener C; Flaujac C; Ibrahim F; Gouin-Thibault I; Bazin M; Sogni P; Samama CM
    Eur J Anaesthesiol; 2016 Feb; 33(2):126-33. PubMed ID: 26258657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.
    Naffouje SA; O'Donoghue C; Salti GI
    J Surg Oncol; 2016 Apr; 113(5):544-7. PubMed ID: 26750613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin.
    Pérez-Ruixo C; Valenzuela B; Peris JE; Bretcha-Boix P; Escudero-Ortiz V; Farré-Alegre J; Pérez-Ruixo JJ
    AAPS J; 2016 Jan; 18(1):239-50. PubMed ID: 26577587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
    Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
    Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery.
    Olde Engberink RH; Kuiper GJ; Wetzels RJ; Nelemans PJ; Lance MD; Beckers EA; Henskens YM
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):210-6. PubMed ID: 24630470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Dagbert F; Thievenaz R; Decullier E; Bakrin N; Cotte E; Rousset P; Vaudoyer D; Passot G; Glehen O
    Ann Surg Oncol; 2016 Jun; 23(6):1980-5. PubMed ID: 26913716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation Profile after Spontaneous Intracerebral Hemorrhage: A Cohort Study.
    Lauridsen SV; Hvas AM; Sandgaard E; Gyldenholm T; Rahbek C; Hjort N; Tønnesen EK; Hvas CL
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2951-2961. PubMed ID: 30072172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
    Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
    Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.